Canaccord Genuity Reiterates Buy on Aspen Aerogels, Maintains $14 Price Target
Portfolio Pulse from richadhand@benzinga.com
Canaccord Genuity analyst George Gianarikas reiterated a Buy rating on Aspen Aerogels (NYSE: ASPN) and maintained a $14 price target.
June 16, 2023 | 2:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Canaccord Genuity analyst George Gianarikas reiterated a Buy rating on Aspen Aerogels (NYSE: ASPN) and maintained a $14 price target.
The reiteration of a Buy rating and maintenance of a $14 price target by Canaccord Genuity analyst George Gianarikas indicates a positive outlook for Aspen Aerogels (NYSE: ASPN) in the short term. This news is likely to have a positive impact on the stock price as it shows confidence in the company's performance and potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100